?-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

Gnehnusee
2021-02-05

?

Foreign media: AstraZeneca vaccine is 75% effective against British mutant virus

据华尔街日报2月5日报道，英国牛津大学和阿斯利康联合开发的新冠疫苗对英国发现的变异毒株的有效率为75%。华尔街日报强调，以上发现来自小规模研究，且是初步的结果，还没有得到其他科学家的正式审查。另外，据

Foreign media: AstraZeneca vaccine is 75% effective against British mutant virus

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":380651463,"tweetId":"380651463","gmtCreate":1612537854852,"gmtModify":1704872644539,"author":{"id":3572057606547842,"idStr":"3572057606547842","authorId":3572057606547842,"authorIdStr":"3572057606547842","name":"Gnehnusee","avatar":"https://static.tigerbbs.com/2d7451bae30652109027611b94e0a24a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>?</p></body></html>","htmlText":"<html><head></head><body><p>?</p></body></html>","text":"?","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/380651463","repostId":1157280058,"repostType":4,"repost":{"id":"1157280058","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1612537534,"share":"https://ttm.financial/m/news/1157280058?lang=en_US&edition=fundamental","pubTime":"2021-02-05 23:05","market":"us","language":"zh","title":"Foreign media: AstraZeneca vaccine is 75% effective against British mutant virus","url":"https://stock-news.laohu8.com/highlight/detail?id=1157280058","media":"老虎资讯综合","summary":"据华尔街日报2月5日报道，英国牛津大学和阿斯利康联合开发的新冠疫苗对英国发现的变异毒株的有效率为75%。华尔街日报强调，以上发现来自小规模研究，且是初步的结果，还没有得到其他科学家的正式审查。另外，据","content":"<p>According to a report by the Wall Street Journal on February 5, the University of Oxford and<a href=\"https://laohu8.com/S/AZN\">AstraZeneca</a>The jointly developed COVID-19 vaccine is 75% effective against the mutant strain found in the UK. The Wall Street Journal stressed that the above findings come from small-scale studies and are preliminary results, which have not been formally reviewed by other scientists.</p><p>Separately, according to Reuters news on February 5, Andrew Pollard, the lead researcher of the Oxford vaccine trial, said that data from the ChAdOx1 vaccine trial conducted in the UK showed that AstraZeneca/Oxford COVID-19 vaccine can not only resist the initial virus, but also resist the new variant B.1. 1.7.</p><p><img src=\"https://static.tigerbbs.com/7666bb12f6c3624d68cf49ea0a835c5d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Foreign media: AstraZeneca vaccine is 75% effective against British mutant virus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForeign media: AstraZeneca vaccine is 75% effective against British mutant virus\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-02-05 23:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>According to a report by the Wall Street Journal on February 5, the University of Oxford and<a href=\"https://laohu8.com/S/AZN\">AstraZeneca</a>The jointly developed COVID-19 vaccine is 75% effective against the mutant strain found in the UK. The Wall Street Journal stressed that the above findings come from small-scale studies and are preliminary results, which have not been formally reviewed by other scientists.</p><p>Separately, according to Reuters news on February 5, Andrew Pollard, the lead researcher of the Oxford vaccine trial, said that data from the ChAdOx1 vaccine trial conducted in the UK showed that AstraZeneca/Oxford COVID-19 vaccine can not only resist the initial virus, but also resist the new variant B.1. 1.7.</p><p><img src=\"https://static.tigerbbs.com/7666bb12f6c3624d68cf49ea0a835c5d\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/82498704f805f2f46f40d2a1a0e8b335","relate_stocks":{"AZN":"阿斯利康","AZN.UK":"阿斯利康制药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157280058","content_text":"据华尔街日报2月5日报道，英国牛津大学和阿斯利康联合开发的新冠疫苗对英国发现的变异毒株的有效率为75%。华尔街日报强调，以上发现来自小规模研究，且是初步的结果，还没有得到其他科学家的正式审查。另外，据路透社2月5日消息，牛津疫苗试验的首席研究员安德鲁·波拉德表示，在英国进行的ChAdOx1疫苗试验的数据表明，阿斯利康/牛津新冠疫苗不仅可以抵御最初的病毒，还可以抵御新变体B.1.1.7。","news_type":1,"symbols_score_info":{"AZN.UK":0.9,"AZN":0.9}},"isVote":1,"tweetType":1,"viewCount":1969,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}